A facile one-pot synthesis of colloidal stable , monodisperse , highly PEGylated CuS @ mSiO 2 nanocomposites for the combination of photothermal therapy and chemotherapy
Feng Lu,Jinfeng Wang,Lin Yang,Jun‐Jie Zhu
2015-01-01
Abstract:Benefiting from the unique physicochemical properties of nanoparticles, nanomedicine has become a rapidly growing and heavily explored field, providing an alternative way for cancer treatment. On the one hand, nanocarriers can take advantage of the enhanced permeation and retention (EPR) effect to deliver therapeutic agents to tumor sites, which is well known as the passive targeting effect. On the other hand, nanoparticles provide a versatile platform for the integration of multimodal therapies, such as chemotherapy, hyperthermia, photodynamic therapy and radiation therapy. Among them, mesoporous silica nanoparticles (mSiO2) with high payload capacity, good biocompatibility and ease of surface modification, have been widely investigated as potential drug carriers. In particular, mSiO2 can be integrated with photothermal agents for a combination of photothermal and chemotherapy, which can provide a high therapeutic index with synergistic effects. However, mSiO2 always suffer from poor colloidal stability in aqueous solution, which results in a rapid unintentional uptake by the reticuloendothelial system and greatly restricts their clinical application. Polyethylene glycol (PEG) grafting is one of the most popular strategies for surface passivation to improve the colloidal stability and enhance the EPR effect. Therefore, photothermal agent coated with a PEGylated mSiO2 layer provides a standard modality for the synergy of photothermal therapy and chemotherapy towards cancer treatment. Recently, copper sulfide nanoparticles (CuS NPs) have emerged as a new class of photothermal agents due to their low cost, good biocompatibility and high extinction in the near infrared range. Furthermore, CuS nanoparticles are more stable under laser irradiation compared with traditional gold nanostructures. Thus the fabrication of PEGylated mesoporous silica coated copper sulfide (CuS@mSiO2–PEG) nanocomposites provides a useful platform for dual cancer treatment. In nanotechnology, a key challenge in the synthesis of these multicomponent nanoparticles towards biomedical applications is obtaining reproducible, monodisperse, colloidal stable nanoparticles in the minimum number of steps. Although PEGylated mSiO2 coated gold nanorod, Cu9S5, graphene and carbon nanotubes were already synthesized, these methods require multiple steps, which makes the process complicated and reduces the reproducibility. And most of the synthesis methods involve reactions in organic solvents, which is not favored for biomedical applications. Importantly, PEGylation on these already formed mSiO2 cannot lead to colloidal stable nanoparticles in most cases due to their poor PEG grafting efficiency. Meanwhile, although PEG grafting enables many characterizations essential for in vivo applications (prevents protein adsorption, lower hemolytic activity, reduces nonspecific cell uptake, enhances blood circulation time and improves passive target efficacy), these benefits only become effective under high coverage density. Thus, a simple and convenient method for highly PEGylated mesoporous silica-based nanocomposites is highly required to bring these nanoparticles into clinical applications. Herein, we present a facile one-pot approach for the synthesis of colloidal stable, highly PEGylated CuS@mSiO2 nanocomposites in aqueous solution. This method is straightforward to achieve the final product, but also can be paused in between to obtain CuS and CuS@mSiO2 nanoparticles. The as-prepared nanocomposites were of sub-50 nm size, monodisperse and highly stable in aqueous solution. Meanwhile they exhibited good photothermal efficacy and pH-responsive drug release behavior. A fast intercellular release and drug accumulation in the nucleus was also observed via a direct in vitro experiment. All these features make the as-prepared CuS@mSiO2–PEG nanocomposites excellent vehicles for the combination of chemo–photothermal therapy. In addition, there State Key Laboratory of Analytical Chemistry for Life Science, Collaborative Innovation Center of Chemistry for Life Science, School of Chemistry and, Chemical Engineering, Nanjing University, Nanjing 210093, P. R. China. E-mail: jjzhu@nju.edu.cn; Fax: +86-25-8359-7204; Tel: +86-25-8359-7204 † Electronic supplementary information (ESI) available: Experimental details, FTIR, PL and UV-vis spectra, and TEM, XRD, BET and MTT data. See DOI: 10.1039/c5cc01725d Received 27th February 2015, Accepted 30th April 2015